Literature DB >> 15956655

High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors.

Cathy D Vocke1, Youfeng Yang, Christian P Pavlovich, Laura S Schmidt, Michael L Nickerson, Carlos A Torres-Cabala, Maria J Merino, McClellan M Walther, Berton Zbar, W Marston Linehan.   

Abstract

The Birt-Hogg-Dubé (BHD) syndrome is an inherited genodermatosis characterized by a predisposition to hamartomatous skin lesions, pulmonary cysts, and renal carcinoma. Seventy-seven renal tumors from 12 patients with germline BHD mutations were examined by DNA sequencing to identify somatic mutations in the second copy of BHD. Sequence alterations were detected in the majority of renal tumors (41 of 77, 53%), with loss of heterozygosity at the BHD locus in a minority of additional tumors (14 of 77, 17%). The somatic mutations were distributed across the entire gene, and the majority resulted in frameshifts that are predicted to truncate the BHD protein. These results support a role for BHD as a tumor suppressor gene that predisposes to the development of renal tumors when both copies are inactivated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956655     DOI: 10.1093/jnci/dji154

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  95 in total

Review 1.  Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

2.  Loss of heterozygosity at the FLCN locus in early renal cystic lesions in dogs with renal cystadenocarcinoma and nodular dermatofibrosis.

Authors:  Tina B Bønsdorff; Johan H Jansen; Ragnar F Thomassen; Frode Lingaas
Journal:  Mamm Genome       Date:  2009-04-23       Impact factor: 2.957

3.  Identification and characterization of a novel folliculin-interacting protein FNIP2.

Authors:  Hisashi Hasumi; Masaya Baba; Seung-Beom Hong; Yukiko Hasumi; Ying Huang; Masahiro Yao; Vladimir A Valera; W Marston Linehan; Laura S Schmidt
Journal:  Gene       Date:  2008-03-04       Impact factor: 3.688

4.  The folliculin mutation database: an online database of mutations associated with Birt-Hogg-Dubé syndrome.

Authors:  Ming-Hui Wei; Patrick W Blake; Julia Shevchenko; Jorge R Toro
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

5.  Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.

Authors:  Laura Maria Pradella; Martin Lang; Ivana Kurelac; Elisa Mariani; Flora Guerra; Roberta Zuntini; Giovanni Tallini; Alan MacKay; Jorge S Reis-Filho; Marco Seri; Daniela Turchetti; Giuseppe Gasparre
Journal:  Eur J Hum Genet       Date:  2013-02-06       Impact factor: 4.246

6.  The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.

Authors:  T R Hartman; E Nicolas; A Klein-Szanto; T Al-Saleem; T P Cash; M C Simon; E P Henske
Journal:  Oncogene       Date:  2009-02-23       Impact factor: 9.867

Review 7.  Precision medicine from the renal cancer genome.

Authors:  Yasser Riazalhosseini; Mark Lathrop
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

Review 8.  Molecular basis for the treatment of renal cell carcinoma.

Authors:  Cristina Suárez; Rafael Morales; Eva Muñoz; Jordi Rodón; Claudia M Valverde; Joan Carles
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

9.  The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dubé gene pathway.

Authors:  Youfeng Yang; Hesed M Padilla-Nash; Manish A Vira; Mones S Abu-Asab; Daniel Val; Robert Worrell; Maria Tsokos; Maria J Merino; Christian P Pavlovich; Thomas Ried; W Marston Linehan; Cathy D Vocke
Journal:  Cancer Genet Cytogenet       Date:  2008-01-15

Review 10.  Molecular diagnosis and therapy of kidney cancer.

Authors:  W Marston Linehan; Gennady Bratslavsky; Peter A Pinto; Laura S Schmidt; Len Neckers; Donald P Bottaro; Ramaprasad Srinivasan
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.